Innovation

Vyripharm helping standardize cannabinoid-based drugs in Texas


By Christine Hall | January 19, 2018

The future of the Texas Compassionate Use Program, which will allow some physicians to treat epilepsy with cannabinoid-based drugs, is right here at the Texas Medical Center.

At a meeting in early January, Vyripharm Biopharmaceuticals explained to a group of politicians, decision makers and medical cannabinoid advocates how the company is educating the state legislature on the best way to implement the program.

The Texas Compassionate Use Act, signed into law on June 1, 2015, created a state licensing program for “dispensing organizations” to provide cannabis-based drugs and for doctors prescribing the drugs to join a physician registry and share information about dosages and administration.

As of December 2017, three dispensing organizations were chosen, and the companies are expected to begin dispensing in early 2018, according to media reports. Vyripharm, located in the TMC Innovation Institute’s TMCx+ incubator space, is assisting with setting the standards and guidelines for the companies as the Compassionate Use Program gets underway.

As part of the meeting, guests toured the company’s research laboratories at The University of Texas MD Anderson Cancer Center and the Medical Botanical Center of Excellence at the University of Houston’s Innovation Center in partnership with Shimadzu, a scientific instruments company.

“The Medical Botanical Center of Excellence is the first fully-comprehensive pharmaceutical and medical botanical testing blockchain platform in Texas,” Elias Jackson, Ph.D., director of scientific public relations at Vyripharm, said. “This has been four years in the making and will allow patients to have pharmaceutical grade cannabinoid products across the board.”

Vyripharm aims to set the standard in the implementation of Compassionate Use programs across the country. The center’s facility follows the same U.S. Drug Enforcement Administration and U.S. Food and Drug Administration standards set for the pharmaceutical industry, he said.

By following the product from seed to patient, Vyripharm aims to meet the needs of Texas’s program by creating guidelines that will ensure the products are safe and consistent.

“If you go to the drugstore to get Tylenol for your fever, you know you are getting the same level of acetaminophen wherever you go,” said Tori Strong, Ph.D., Vyripharm’s director of intellectual property and technology. “This is the same thing we want to do with cannabinoids.”

In addition, the company wants to research the specific effects of cannabinoids in individual patients.

“Soon, we will be able to find out how an initial dose of cannabinoids is being used by the body in a particular person, know exactly what works for them and be able to dose according to their characteristics,” Jackson said.




Social Posts

profile_image

MD Anderson Cancer Center

@MDAndersonNews

RT @KirstiClifford: Rounding with @ppisters and @CarolPorterDNP was extra special today as we recognized our amazing staff @MDAndersonNews…

19 mins ago
profile_image

BCMHouston

@bcmhouston

RT @BCMSpaceHealth: Attention all researchers & scientists. Join Stephen Mayo and TRISH research #spacehealth.Information can be found he…

25 mins ago
profile_image

UTHealth

@UTHealth

RT @UTPhysicians: Dr. Stuart Harlin will be a guest on KPRC TV Channel 2’s Houston Life. At 1:30 today, he will be discussing varicose and…

27 mins ago
profile_image

Harris Health System

@harrishealth

Reduce your risk of cancer - RE: @WHO https://t.co/DGDoZCOXj5

30 mins ago
profile_image

UTMB Health

@utmbhealth

RT @ppisters: I enjoyed my visit yesterday with @utmbhealth president Dr. David Callender and his team. Great tour and time spent learning…

35 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Eye cancer survivor Tina Ladowski: "Suddenly, there was hope where none had been before." https://t.co/3cEQhyBpit #Rarecancer @MDAProtons #endcancer https://t.co/7tfmqvlqsB

47 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

Colorado’s new Rocky Mountain Regional VA Medical Center is open for business https://t.co/btQdn6UuSi via #VAntagePoint

52 mins ago
profile_image

University of Houston

@UHouston

Two University of Houston students and a faculty member, striving to set examples for future generations of women. #GoCoogs! https://t.co/xZWa98q6aW

53 mins ago
profile_image

University of Houston

@UHouston

RT @uhparking: Did you know? Our team has been working hard to get parking permits ready and sent out, so be sure to keep an eye out for yo…

55 mins ago
profile_image

Rice University

@RiceUniversity

RT @RiceUNews: #Houston and #HarrisCounty's serious flooding problems can be solved if funding is available and both the public and local o…

1 hour ago
profile_image

Rice University

@RiceUniversity

Rice’s Disability Support Services has changed its name to the Rice Disability Resource Center to reflect its expanded scope of services offered: https://t.co/63eC9pJn8d https://t.co/UVQXuqI5Qx

2 hours ago
profile_image

BCMHouston

@bcmhouston

Learn how Graduate School of Biomedical Sciences student Jamie Reyes decided to get into research after his grandfather's death. https://t.co/qtE4duuobR #students

2 hours ago
profile_image

BCMHouston

@bcmhouston

Family members and guests joined first-year medical students at Baylor College of Medicine's Family Day on Aug. 11, 2018. The event included campus tours and faculty presentations. View more photos on our Facebook page. https://t.co/PZD1zqjBXL https://t.co/97fj6gZkI2

2 hours ago
profile_image

UTMB Health

@utmbhealth

RT @utmbnews: See the @noticiashouston segment with our own Dr. Cortiella speaking about bioengineering lungs: Investigadores de Texas adel…

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Tom, a @USArmy Veteran, reconnected with some of his battle buddies years after their service. He finds relief in the camaraderie of being around Veterans who experienced challenges like his own. Hear his story: https://t.co/JERUKq7VeA https://t.co/AW42GALdGO

2 hours ago